Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 202.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 485.00
  • 52 Week Low: 195.00
  • Currency: UK Pounds
  • Shares Issued: 55.26m
  • Volume: 0
  • Market Cap: 111.91m

FARN Overview

We are a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system in order to tackle cancer and inflammation. Since our founding in 2007, our goal has been to develop a diverse and unique pipeline rooted in high quality science and innovation. Faron is focused on mastering immune modulation by harnessing endothelial receptors to control and mediate immune responses.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a -1254896.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 45.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FARN Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (21.06) (75.98)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 0.02 (20.08) (64.99)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (13.25) (36.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (16.93) (37.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (21.18) (42.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

FARN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 0.00 (21.22) (37.78)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.14 (12.26) (18.93)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

FARN Company Announcements

Notice of Half-Year Financial Results 08-Aug-2022 07:00 RNS
Results of EGM 07-Jul-2022 09:45 RNS
Holding(s) in Company 30-Jun-2022 17:00 RNS

Latest FARN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

FARN Market Data

Currency UK Pounds
Share Price 202.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 485.00
52 Week Low 195.00
Volume 0
Shares Issued 55.26m
Market Cap 111.91m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
9.38% below the sector average9.38% below the sector average9.38% below the sector average9.38% below the sector average9.38% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for --2022

Time Volume / Share Price
0 @ 0.000p

FARN Key Personnel

CEO Markku Jalkanen

Top of Page